Dr. Eric Walk is chief medical officer at PathAI in Boston, MA. He is head of the medical group, overseeing the medical affairs, clinical science, and regulatory functions.
Walk has over 20 years of experience in precision medicine, including oncology drug development, companion diagnostics development, and AI pathology. Prior to joining PathAI, he was chief medical and scientific officer at Roche Tissue Diagnostics/Ventana Medical Systems, where he led medical & scientific affairs, overseeing the validation and FDA clearance/approval of multiple IVD assays, companion diagnostics, and digital pathology algorithms.
Walk began his industry career at Novartis Oncology, where he held positions in early clinical development and translational medicine, working to implement biomarker and precision medicine strategies for early and late stage targeted oncology therapeutics.
Walk is a Phi Beta Kappa graduate of Johns Hopkins University and holds a MD degree from the University of Virginia School of Medicine. He is board certified in anatomic and clinical pathology and is a Fellow of the College of American Pathologists (CAP). He is currently a member of the CAP Digital & Computational Pathology Committee, SITC Pathology Committee, and Digital Pathology Association (DPA) Board.
Articles by Eric E. Walk, MD, FCAP
